ENALAPRIL IN CHRONIC HEART-FAILURE - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL

被引:0
|
作者
SHARPE, N [1 ]
MURPHY, J [1 ]
COXON, R [1 ]
机构
[1] UNIV AUCKLAND,SCH MED,DEPT MED,AUCKLAND,NEW ZEALAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:471 / 471
页数:1
相关论文
共 50 条
  • [21] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE LONG-TERM EFFICACY OF CARVEDILOL IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE
    KRUM, H
    SACKNERBERNSTEIN, JD
    GOLDSMITH, RL
    KUKIN, ML
    SCHWARTZ, B
    PENN, J
    MEDINA, N
    YUSHAK, M
    HORN, E
    KATZ, SD
    LEVIN, HR
    NEUBERG, GW
    DELONG, G
    PACKER, M
    [J]. CIRCULATION, 1995, 92 (06) : 1499 - 1506
  • [22] EFFECTIVITY OF DIGITALIS IN PATIENTS WITH CHRONIC HEART-FAILURE AND SINUS RHYTHM - AN OVERVIEW OF RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    KRAUS, F
    RUDOLPH, C
    RUDOLPH, W
    [J]. HERZ, 1993, 18 (02) : 95 - 117
  • [23] DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL OF LONG-TERM CAPTOPRIL HEART-FAILURE THERAPY
    FITZPATRICK, D
    IKRAM, H
    NICHOLLS, MG
    [J]. CIRCULATION, 1983, 68 (04) : 130 - 130
  • [24] LONG-TERM CLINICAL EFFECT OF NILVADIPINE IN PATIENTS WITH CHRONIC HEART-FAILURE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    HORI, M
    SATO, H
    KARITA, M
    KODAMA, K
    HOKI, N
    HAYASHI, T
    NAKA, M
    NANTO, S
    YAMADA, Y
    KAMADA, T
    [J]. HEART AND VESSELS, 1994, 9 (05) : 249 - 253
  • [25] Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial
    Granger, BB
    Swedberg, K
    Ekman, I
    Granger, CB
    Olofsson, B
    McMurray, JJV
    Yusuf, S
    Michelson, EL
    Pfeffer, MA
    [J]. LANCET, 2005, 366 (9502): : 2005 - 2011
  • [26] The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
    Du, Kangjia
    Liu, Junjie
    Tan, Nannan
    Huang, Xinyi
    Wang, Juan
    Zhao, Huihui
    Wang, Wei
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] Ursodeoxycholic acid in patients with chronic heart failure. A double-blind, randomized, placebo-controlled, crossover trial
    Von Haehling, S.
    Schefold, J. C.
    Jankowska, E. A.
    Springer, J.
    Vazir, A.
    Kalra, P. R.
    Sandek, A.
    Fauler, G.
    Stojakovic, T.
    Trauner, M.
    Ponikowski, P.
    Volk, H-D.
    Doehner, W.
    Coats, A. J. S.
    Poole-Wilson, P. A.
    Anker, S. D.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (01) : 110 - 117
  • [28] DOUBLE-BLIND RANDOMIZED CROSSOVER TRIAL OF TAURINE IN CONGESTIVE HEART-FAILURE
    AZUMA, J
    SAWAMURA, A
    AWATA, N
    HASEGAWA, H
    OGURA, K
    HARADA, H
    OHTA, H
    YAMAUCHI, K
    KISHIMOTO, S
    YAMAGAMI, T
    UEDA, E
    ISHIYAMA, T
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 34 (04): : 543 - 557
  • [29] XIPAMIDE TREATMENT IN CONGESTIVE HEART-FAILURE - DOUBLE-BLIND TRIAL WITH FUROSEMIDE
    BONADUCE, D
    FERRARA, N
    CANONICO, V
    VISCIOLA, G
    POSTIGLIONE, M
    RENGO, F
    CONDORELLI, M
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 31 (03): : 293 - 301
  • [30] Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
    Tavazzi, Luigi
    Maggioni, Aldo P.
    Marchioli, Roberto
    Barlera, Simona
    Franzosi, Maria Grazia
    Latini, Roberto
    Lucci, Donata
    Nicolosi, Gian Luigi
    Porcu, Maurizio
    Tognoni, Gianni
    [J]. LANCET, 2008, 372 (9645): : 1231 - 1239